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TNF-αNuclear Matrix and MARs have been implicated in the transcriptional regulation of host as well as viral genes
but their precise role in HIV-1 transcription remains unclear. Here, we show that N98% of HIV sequences
contain consensus MAR element in their promoter. We show that SMAR1 binds to the LTR MAR and
reinforces transcriptional silencing by tethering the LTR MAR to nuclear matrix. SMAR1 associated HDAC1-
mSin3 corepressor complex is dislodged from the LTR upon cellular activation by PMA/TNFα leading to an
increase in the acetylation and a reduction in the trimethylation of histones, associated with the recruitment
of RNA Polymerase II on the LTR. Overexpression of SMAR1 lead to reduction in LTR mediated transcription,
both in a Tat dependent and independent manner, resulting in a decreased virion production. These results
demonstrate the role of SMAR1 in regulating viral transcription by alternative compartmentalization of LTR
between the nuclear matrix and chromatin.).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Human Immunodeﬁciency Virus Type 1 (HIV-1) is the etiological
agent of AIDS and AIDS-related complex (ARC) (Barre-Sinoussi et al.,
1983). Among the various steps of viral life cycle, the transcription
from HIV-1 provirus is essential for ampliﬁcation of the viral genes
and considered crucial for viral replication. HIV-1 transcription is
directed by the promoter located at 5′ long terminal repeat (LTR) of
the integrated provirus and is basically segmented into three well
deﬁned regions; a negative regulatory element (NRE) region, an
enhancer region, and a trans-acting region (Naghavi et al., 1999). The
NRE contains a number of recognition sequences for cellular
transcription factors, the deletion of which results in an increase of
both reporter gene transcription and viral replication (Gaynor, 1992).
However, information regarding the mechanism by which NRE exerts
its negative effect on viral transcription is unknown because most of
the transcription factors that bind to NRE are transcriptional
activators. The DNA elements important for the LTR activity are
located between −454 and +1884 nucleotides, where +1 is the
transcription start site. This region contains the TATA box and binding
sites for host transcription factors Sp1 and NF-κB, etc (Copeland,
2005; Korner et al., 1990). These binding sites and their relativeorientations together mediate DNA–protein and protein–protein
interactions that form a complex regulatory network. While activa-
tion of the LTR is associated with changes in chromatin structure,
the mechanisms governing repression of LTR are not completely
understood.
Multiple cellular factors like YY-1, c-Myc, p50, CTIP2, CBF-1 and
AP-4 that recruit histone deacetylase (HDAC) to LTR are known to
negatively regulate HIV transcription (Imai and Okamoto, 2006; Du et
al., 2007; Jiang et al., 2007; Marban et al., 2007; Tyagi and Karn, 2007;
Williams et al., 2007). Analysis of latently infected virus as compared
to actively transcribing ones reveal epigenetic restrictions involving
chromatin modiﬁcations responsible for subduing of transcription in
the latent state. Pearson et al. (2008) show that upon activation of
latent virus with TNF-α, there is signiﬁcant reduction in the histone
methylation with concomitant increase in acetylation and also
reduced association of HP1-α. Thus, although the signal for activation
or repression of transcription at LTR seems to be regulated to some
extent by external stimuli, the actual ground rules are set by
epigenetic modiﬁcations at the LTR.
In this context, the role of nuclear milieu and cis regulatory
elements proximal to the sites of viral integration assumes importance
(Copeland, 2005; Lassen et al., 2004). MARs are typically ∼200 bp long
AT-rich DNA sequences, characterized by duplex instability, duplex
ﬂexibility due to AT-richness, apart from DNaseI hypersensitivity,
Topoisomerase II cleavage sites and a high afﬁnity for binding to
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Bisgrove et al., 2005; Dijkwel and Hamlin, 1988). NM is usually
associated with inner nuclear membrane (INM) which is constituted
by a distinct set of proteins such as LBR, LAP2 and Emerin as well as an
underlying nuclear lamina, which have been proposed to interact with
transcriptional repressors such as Sp1, SATB1 etc. (Guelen et al., 2008;
Zhang et al., 1996). Another function of the NM is in concentrating and
localizing various transcription factors which are present in limited
amounts in the nucleus (Heessen and Fornerod, 2007). Moreover,
recent studies have shown that transcriptional repression is mediated
by repositioning of genes to the nuclear lamina and activation is
mediated by repositioning to transcription factories (Reddy et al.,
2008). There are several reports showing that a MAR from one species
can bind to nuclear matrix preparations from another species (Breyne
et al., 1992; Seo et al., 2005).
The expression of integratedHIV in infected latent cells is regulated
at the level of transcription by cellular factors and the viral
transactivator Tat. The HIV LTR contains cis-acting elements required
for transcriptional initiation and binding sites for various transcription
factors like Sp1, NF-κB, and NF-AT etc. These factors are known to
regulate transcription based on the stimulus they get. Although
signaling mechanisms that lead to viral activation have been worked
out, the chromatin modifying factors and mechanisms involved
therein are not clear.
In this context, the current study evaluates the role ofMAR elements
in LTR and a speciﬁc MAR binding protein SMAR1 in regulating viral
transcription. This study stems from the fact that HIV-1 integration sites
areﬂankedbypotentialMARs (Kulkarni et al., 2004). The transcriptional
repressor function of a nuclear matrix attachment region binding
protein SMAR1 has been well documented for genes like Cyclin D1 and
CK8 through recruitment of Sin3/HDAC1 complex to the target
sequence (Rampalli et al., 2005; Pavithra et al., 2009).
Our studies for the ﬁrst time conﬁrm the presence of conserved
MARs in the 5′ LTRs of most of the HIV strains and indicate the
binding of SMAR1 to this MAR in latent state. Interestingly, these
MARs are capable of binding to nuclear matrix in unactivated but
not in activated cells, suggesting a direct role of nuclear matrix in
regulating viral latency. We demonstrate that SMAR1 acts as a
repressor of HIV-1 LTR promoter both in presence and absence of
transactivator Tat. Further, SMAR1 maintains the latent state of
viral transcription by recruiting HDAC1-mSin3a corepressor com-
plex, which is dislodged from the LTR MAR upon activation by PMA
and TNFα.
Results
LTRs of all HIV isolates have conserved MAR in their 5′ LTR and SMAR1
anchors HIV- LTR to the Nuclear Matrix
Several reports highlight the importance of MARs in viral
integration and their role in viral transcription (Kulkarni et al.,
2004) but the mechanism by which they elicit these effects is not yet
understood. Although NRE of LTR is known to bind to nuclear matrix,
whether there are conserved matrix attachment regions in all the HIV
strains is not known. To address this, we analyzed all the LTRs
available in NCBI nucleotide database for the presence of MARs.
Among the 3742 hits obtained for HIV LTR in GenBank, 223
represented distinct LTRs and were used for further analysis. The
rest weremultiple isolates of the same sequence. Analysis of these 223
LTR sequences for the presence of MARs using MARWIZ software
showed the presence of one or more potential MARs (ρ=1) in N98%
of the LTRs analyzed (219 out of 223) (details of sequences are given
in Supplementary information). We next checked for the possible
consensus elements present in these LTR MARs. For this, MAR
sequences from all the HIV LTRs were analyzed by MEME (Multiple
EM for Motif Elicitation) software (Bailey et al., 2006). MEME analysisof these sequences revealed the presence of a conserved 50-mermotif
spanning -258 to -208 region of HIV LTRwith an error value of 3.3e-810
(Supplementary ﬁgure S1A). A further division of this 50-mer
sequence into distal (WT-A), middle (WT-B) and proximal (WT-C)
sequences revealed the presence of a conserved hexanucleotide
(CAAAGA) in most of the 219 unique LTR- MARs that were analyzed.
Having veriﬁed the presence of conserved MAR elements in these
LTRs, we next addressed if these LTR-MARs contribute to functional
partitioning of the viral genome into chromatin and matrix fractions
upon stimuli. For this, nuclear matrix and chromatin fractions were
isolated from PMA activated or control CEM-GFP cells. Nuclearmatrix-
bound or unbound fractions (chromatin) were used as template in the
PCR to determine the relative amounts of LTR bound to nuclear matrix
under these conditions. The ampliﬁcation of LTR in unbound
chromatin fractions was 5-fold higher in activated as compared to
unactivated cells (Fig. 1A, lanes 1 and 2). In contrast, LTR amplicon
was ∼3-fold less in nuclear matrix from activated cells compared to
unactivated cells (Fig. 1A, upper panel, lanes 3 and 4, Fig. 1B). Similar
experiment with p53-AIP promoter which does not have any MAR
element revealed that the promotermostly associatedwith chromatin
fraction in control cells and there was no change in its association
upon activation by PMA (Fig. 1A, lower panel, lanes 1 and 2). This
shows that the LTR is sequestered in the nuclear matrix under latent
conditions while upon cellular activation, it is displaced to the active
chromatin.
Considering that matrix associated proteins play a major role as
transcriptional repressors, we checked if SMAR1which is known to be
aMAR-binding protein is a component of nuclear matrix. Immunoblot
analysis showed the presence of SMAR1 in nuclear matrix under
endogenous conditions both in Jurkat and HeLa cells (Fig. 1C). Further,
in vitro and in vivo matrix binding assays in SMAR1 overexpressed/
knockdown/PMA activated cells were performed to check if SMAR1 is
essential for anchoring LTR to the nuclear matrix. Overexpression of
SMAR1 led to an increase in the amount of LTR-MAR bound to nuclear
matrix (Fig. 1D, lane 3), whereas PMA-mediated activation and
SMAR1-SiRNA led to a lower amount of LTR-MAR bound to nuclear
matrix (Fig. 1D, lanes 4 and 5). Knock-down and overexpression of
SMAR1 was conﬁrmed by immunoblotting (Supplementary ﬁgure
S1B). Upon immunoblot analysis of SMAR1 in TZM-bl cells, we
observed a reduction of SMAR1 protein in the nuclear matrix fraction
upon activation while there was no change in the chromatin fraction
(Fig. 1E, lanes 2 and 4). This is consistentwith our earlier observations.
Purity of the nuclearmatrix and chromatin fractionswas conﬁrmed by
immunoblotting for Lamin B1 andHistoneH1 respectively. HistoneH1
levels in chromatin fraction are reduced upon activation, since it is
evicted from the chromatin during transcriptional activation to
maintain active chromatin state. To visualize the levels of SMAR1 in
nuclear matrix in control and activated TZM-bl cells, in-situ nuclear
matrix staining for SMAR1 was performed. There was a time
dependent reduction of SMAR1 in nuclear matrix upon activation by
PMA. Interestingly, we ﬁnd that SMAR1 localizes to nuclear periphery
upon activation by PMA (Supplementary ﬁgure S1D). Further, South-
Western blotting in HeLa nuclear matrix with LTR-MAR as probe
showed a band at 55 kDa that corresponds to SMAR1 band in
immunoblot analysis (Supplementary ﬁgure S1C). Taken together,
these results are suggestive of the binding of nuclear matrix
component SMAR1 to the HIV LTR MAR.
SMAR1 binds to conserved MAR sequence within HIV-1 LTR
We next evaluated the direct binding of SMAR1 to the HIV LTR
MAR. Gel shift assays using the recombinant protein revealed binding
of SMAR1 to the 200 bp full length LTR-MAR (-350 to -150) in vitro
(Fig. 2A, lanes 3, 4 and 5). One hundred-fold excess non-speciﬁc
competitor (NS) could not reduce the complex formation (Fig. 2A,
lane 6) while there was a signiﬁcant reduction in the complex
Fig. 1. SMAR1 anchors HIV-1 LTR to the nuclear matrix. (A) In vivo matrix binding assay showing displacement of LTR to Chromatin from nuclear matrix upon activation. Nuclear
matrix and chromatin fractions were isolated from control CEM-GFP cells or cells activated with PMA and DNA associated with these fractions was isolated and LTR and p53-AIP
promoter ampliﬁed using speciﬁc primers. (B) The densitomertric analysis of the same showing fold changes in LTR association in various fractions. (C) Immunoblot analysis of
SMAR1 with Lamin B1 as control in nuclear matrix. Nuclear matrix isolated from Jurkat and HeLa cells was analyzed for presence of SMAR1 by Immunoblot analysis. Lamin B1 was
used as control. (D) In vitro (top) and in vivo (bottom) matrix binding assays showing SMAR1 mediated anchoring of LTR to nuclear matrix. For in vitro matrix binding assay,
radiolabeled LTR-MARwas incubated with nuclear matrix fraction isolated from control CEM-GFP cells (Ctrl), SMAR1 overexpressed (SM), SMAR1 knockdown (Si) or PMA activated
cells for 1 h at 37 °C, washed three times with Tris-buffer containing 2MNaCl, pH 7.8. The matrix bound DNA fragments were resolved on 10% native PAGE. In in vivo assay, LTR-MAR
was PCR ampliﬁed from the same samples. (E) Immunoblot analysis of SMAR1 in different cellular fractions upon activation by 50 ng/ml of PMA. Fortymicrograms each of chromatin
and nuclear matrix fractions from control CEM-GFP cells or cells activatedwith PMAwere resolved in 12% SDS-PAGE and analyzed for expression of SMAR1. Lamin B1 and Histone H1
were used as controls for nuclear matrix and chromatin fractions respectively.
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The upstream non-MAR LTR (δ-MAR) region used as control did not
show any complex formation with SMAR1 (Fig. 2B). In an attempt to
map the exact SMAR1 binding sequence in the LTR-MAR, we
synthesized oligos corresponding to WT-A (nucleotides towards 5′
end of LTR-MAR, WT-B (sequence at the middle of LTR-MAR), WT-C
(nucleotides towards 3′ end of LTR-MAR) and WT-6 as described in
Table 1. WT-A and WT-B failed to show any binding to GST-SMAR1
(Supplementary Fig. S2A, B), whereas the probe WT-C which spans
the 3′ end of the consensus MAR showed a strong complex formation
with SMAR1 (Fig. 2C, lanes 3 and 4). A DNA-binding mutant of SMAR1
protein (160–350 aa) did not show any complex formation with the
probe (Fig. 2C, lane 5) showing the speciﬁcity of the binding. Further,
to identify the exact bases which are necessary for binding of SMAR1
to LTR-MAR, we introduced more mutations in WT-C. Detailed
description of these oligos and the mutants used are documented in
Table 1. The mutation of all three ‘A’s to ‘G’ (Mut3xA), mutation of ‘G’
at position 7 to ‘A’ (MutG) (Fig. 2D and S1C, D) resulted in the loss ofFig. 2. SMAR1 binds toMAR in HIV-1 LTR in vitro. (A) Gel-shift assay showing binding of recom
was used as probe. The binding speciﬁcity was veriﬁed using 100-fold excess non-speciﬁc
complex formation (Lane 7, self). (B) Probemade from LTRDNAupstreamofMAR did not sho
sequence fromLTR shows complex formationwith recombinant SMAR1. (D) Aminimal hexanSMAR1 binding to the probe. Further, the mutation of ‘T’ to ‘C’ (MutT-
C) and mutation of all ‘A’s to ‘G’ (MutA-G) also resulted in loss of
SMAR1binding (Supplementary Fig. S2 D, E). Therefore, the bases ‘G’
at position 7, and three ‘A’s from position 4 seem to be very critical for
binding of SMAR1 to LTR-MAR. To validate SMAR1 binding to this
consensus element, gel shift assays were performed with tandem
repeats of the conserved hexanucleotide sequence (WT-6) present in
the proximal end of LTR-MAR described in the earlier section. We
observed a strong nucleoprotein complex formation of SMAR1 and
WT-6, conﬁrming that this sequence is the actual SMAR1 binding
sequence in LTR-MAR (Fig. 2D).
SMAR1 remodels chromatin structure at HIV LTR
Recent studies have shown that the presence of HDACs at the HIV
LTR is strongly correlated with transcriptional repression. SMAR1 is
known to recruit HDAC1/Sin3A corepressor complex to various
promoters and repress gene expression (Rampalli et al., 2005;binant SMAR1 protein to HIV LTR. 200 bp full length radiolabeledMAR fromHIV-1pNL4-3
competitor DNA (Lane 6, NS). Ten fold excess unlabelled LTR-MAR led to reduction in
w any complex formation (LTR δ-MAR). (C) 16-mer oligonucleotide from consensusMAR
ucleotide sequence CAAAGA shows strong complex formationwith recombinant SMAR1.
Table 1
Sequences of probes used in Electrophoretic Mobility Shift Assays (EMSAs).
Name of probe Sequence (5′ to 3′)
WT-A CACATGAGCCCAAAGA (−240 to −224)
WT-B GCACATCCGGAGTATC (−257 to −241)
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tested if both SMAR1 and HDAC1 are corecruited to the LTR-MAR by
checking for the ampliﬁcation of LTR-MAR in chromatin fraction
pulled with SMAR1 and subsequently HDAC1. Sequential ChIP
experiments performed in chromatin fractions from Jurkat cells
infected with HIV-1pNL4-3 conﬁrmed the recruitment of SMAR1/
HDAC1 complex to the LTR (Fig. 3B, upper panel). The sequence
downstream of TATA box (LTR-DS shown in Fig. 3A) served as
negative control (Fig. 3B, lower panel). Immunoprecipitation of
chromatin extracts from HIV-1pNL4-3 infected Jurkat cells transfected
with SMAR1 siRNA showed a reduced association of HDAC1 with LTR
(Fig. 3C, lane 3), revealing that SMAR1 is important for recruiting
HDAC1 to LTR.
To study the role of SMAR1 in HIV-1 transcription, ACH-2 cells
were used as an experimentally relevant model of transcriptional
latency. To conﬁrm the induction of virus production, supernatant
from untreated or PMA/TNF-α treated ACH-2 cells were assayed for
p24 antigen. There was approximately a 6 to 7-fold induction of p24
counts upon activation by PMA or TNF-α 24 h post-treatment (Fig.
3D). To map chromatin changes associated with the recruitment of
SMAR1 and Sin3A-HDAC1 co-repressor complex on LTR, ACH-2 cells
were activated with PMA for different time intervals. Ampliﬁcation
of LTR-MAR region (Fig. 3A) from PMA activated chromatin extracts
showed a time-dependent dissociation of SMAR1 from LTR. The
amount of SMAR1 associated with LTR in control cells was high.
Upon activation by PMA, the association reduces rapidly in a time-
dependent manner and after 90 min there was no SMAR1 associated
with LTR (Fig. 4A). Similar pattern was observed in case of HDAC1Fig. 3. SMAR1 binds to MAR in HIV-1 LTR in vivo. (A) Map of HIV LTR and location of primers
SMAR1 and HDAC1 on LTR. Cross-linked chromatin fragments from TZM-bl cells pulled with
which LTR-MARwas ampliﬁed. (C) ChIP experiment showed knockdown of SMAR1 abrogate
or TNF-α.and Sin3A which associate with LTR in unactivated cells and
dissociate at 90 min post activation showing that SMAR1-HDAC1-
Sin3A exist as a complex at LTR and dissociate at the same time
upon activation by PMA. This is correlated to an increased
acetylation of histones at H3K9 and H4K16 and decreased histone
tri-methylation at H4K20 (Fig. 4A, left panel), essential signatures of
a transcriptionally active promoter (Sims and Reinberg, 2008).
Further, there was increased recruitment of RNA Pol II with
corresponding increase in phosphorylation at Serine 2 and Serine 5
indicating an active transcription. Ampliﬁcation of the region
downstream of the TATA box showed no SMAR1 binding to LTR
both in activated and control cells, although a marked time-
dependent increase in the acetylation of histones and RNA Pol II
recruitment, indicative of a spreading effect of histone modifying
enzymes was observed upon activation (Fig. 4A, right panel). To
provide a control for the speciﬁcity of the ChIP assay, the same
samples were analyzed for actin promoter. There was no difference
in RNA Pol II and histones acetylated at H3K9 and H4K16 present at
the actin promoter before and after activation by PMA. Also
immunoprecipitates of SMAR1, HDAC1 and Sin3A did not yield any
ampliﬁcation (Supplementary Fig. S3, left panel).
PMA is known to activate many cellular pathways through
regulation of diverse transcriptional activators like AP-1, Sp1, NF-κB
etc. Therefore, to pinpoint the exact molecular mediators leading to
LTR activation and SMAR1 dissociation, we performed similar ChIP
experiment with 20 ng/ml of TNF-α which activates speciﬁcally NF-
κB pathway. Similar to PMA, TNF-α treatment also lead to dissociation
of SMAR1-HDAC1 complex from LTR MAR, albeit with a delay of ∼15
min in the kinetics (Fig. 4B). Thus, SMAR1, HDAC1 and Sin3A bind to
LTR causing deacetylation of histones which leads to repression of
LTR-mediated transcription (Fig. 4B, left panel). Upon activation of the
cells by PMA or TNF-α, SMAR1 and its associated repressor complex
dissociates from LTR making way for NF-κB to recruit p300 on to LTR
which in turn activates LTR-mediated transcription through acetyla-
tion of histones at LTR. It is known that histone modiﬁcations at
promoters determine the nature of transcription factors that are
recruited to the promoter. Since SMAR1 recruits HDAC1/Sin3A
complex to LTR, it causes deacetylation of histones which leads to
recruitment of other factors that enforce transcriptional repression.
Therefore, SMAR1 plays a major role in creating a repressive
chromatin structure at HIV LTR.used in the study along with major protein binding sites. (B) Sequential ChIP analysis of
α- SMAR1 antibody were eluted and sequentially pulled with α-HDAC1 antibody from
s HDAC1 recruitment to LTR-MAR. (D) p24 ELISA in ACH-2 cells upon activation by PMA
Fig. 4. SMAR1 binds and alters chromatin architecture at HIV LTR. (A) Time kinetics of dissociation of SMAR1/HDAC1/Sin3 complex from latent LTR upon activation by PMA or TNF-
α, creating decondensed chromatin. ACH-2 cells were activated with 50 ng/ml of PMA and chromatin changes associatedwith transcriptional activation at LTRwas followed at every
15 min interval using chromatin immunoprecipitation using antibodies speciﬁc for SMAR1, HDAC1, Sin3A, acetyl H3K9, acetyl H4K16, trimethyl H4K20 and RNA Pol II. The regions
downstream of TATA box in HIV genome and Actin promoter were used as controls. (B) Chromatin immunoprecipitation assay as in (A) with activation by TNF.
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Transcription factors which are part of chromatin remodeling
complex can affect transcription in two ways; one by recruiting
repressor complexes, other by modifying the chromatin structure
through direct binding. Therefore we next assessed the role of SMAR1
in LTR-mediated transcription in TZM-bl cells. There was 2–3 fold
reduction in basal transcription of HIV-1 LTR upon SMAR1 transfection
(Fig. 5A). Moreover, overexpression of SMAR1 could over-ride Tat or
PMA mediated transactivation of LTR, as shown by a 2-fold reduction
in luciferase activity upon overexpression of SMAR1 in presence of Tat
or PMA (Figs. 5B, C). Knockdown of SMAR1 using siRNA resulted in a
signiﬁcant increase in the basal as well as Tat-mediated transcription
(Fig. 5D). There was a 2-fold increase in basal promoter activity and
1.5-fold higher Tat-mediated luciferase activity upon knockdown of
SMAR1. Some chromatin remodeling proteins like SWI/SNF can affect
expression of genes within chromatin and cannot affect transcription
of genes expressed episomally. Therefore, we evaluated if SMAR1
affected LTR mediated transcription when the reporter was trans-
fected exogenously. In transient transfection assays, LTR-Luc construct
was designed to quantitate the LTR driven reporter activity upon
SMAR1 expression in the presence or absence of either Tat or PMA. Our
results showed that SMAR1 overexpression lead to 3-fold reduction in
LTR-mediated transcription (Fig. 5E).We further observed that SMAR1
overexpression could over-ride Tat or PMA mediated transactivation
(Figs. 5F, G) of transfected LTR-luciferase. Knockdown of SMAR1 lead
to a 2-fold increase in both basal and Tat-mediated LTR-Luciferase
activity (Fig. 5H). Taken together, our results suggest that SMAR1
represses viral transcription of both integrated and unintegrated LTRs.
SMAR1 regulates basal HIV transcription
In view of the constitutive binding of SMAR1 to the transcription-
ally silent HIV LTR, we investigated if SMAR1 might be involved inregulating basal transcription from a transcriptionally silent LTR
promoter. SMAR1 knock-down using speciﬁc siRNA or overexpression
in latent ACH-2 cells was conﬁrmed by Western blot analysis using
SMAR1 speciﬁc antibody (Fig. 6A). SMAR1 knockdown resulted in
∼2.5 fold induction in p24 counts, while its overexpression led to a 2-
fold decrease in the p24 levels (Fig. 6B).
The role of SMAR1 in repressing HIV-1 virion production was
further demonstrated by transfection of HeLa cells with infectious
molecular clone pNL4-3 or pYU-2. The culture supernatant was then
tested for the presence of viral protein p24gag. Co-transfection with
SMAR1 caused a dose-dependent inhibition of both CXCR4 (pNL4-3)
and CCR5 (pYU-2)—tropic virus production, whereas cotransfection of
vector control failed to inhibit HIV production. Transfection of siRNA
speciﬁc for SMAR1 increased pYU2 virus production by 2-fold and
pNL4-3 virus production by 2.5-fold compared to control cells. Co-
transfection of pcTat resulted in an increased virion production and
was used as positive control (Figs. 6C, D). These ﬁndings point out at
the role of SMAR1 in the inhibition of HIV-1 replication and virion
production.
Discussion
Transcription from the proviral form, which is a coordinated
interplay of multiple DNA-bound activators, coactivators, inhibitors
and basal transcription components, is one of the most important
steps in the life cycle of HIV (Bisgrove et al., 2005). Although
factors binding to HIV LTR have been well studied, little is known
about factors binding to NRE and their effects thereof. In this
report, we identify the presence of at least one MAR in the 5′ LTR
of different strains of HIV and provide a consensus sequence
present in their MARs. In this context, it would be interesting to
look for similar sequences in 3′ LTR. Since 3′ LTR does not drive
HIV gene expression, how existence of such MARs affects HIV
transcription is debatable. It is apparent that the presence of cis
Fig. 5. SMAR1 downregulates HIV-1 transcription. Luciferase assays in SMAR1 overexpressed TZM-bl cells showing repression of (A) basal, (B) Tat mediated and (C) PMA activated
LTRmediated transcription. (D) Luciferase assays upon SMAR1 knockdown in TZM-bl cells. SMAR1 downregulates basal (E), Tat-mediated (F) and PMA activated (G) transcription in
293T cells transiently transfected with LTR-Luc reporter. (H) Luciferase assays upon SMAR1 knockdown.
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tional control dependent on the nuclear milieu. This is similar to,
the Human Papilloma Viruses (HPVs) that harbor MARs in both the
5′ LCR and the genome that serves to regulate the viral gene
expression. Our observation suggests that binding to nuclear matrix
is a general phenomenon of many viral promoters, a mechanismFig. 6. SMAR1 inhibits basal LTR-mediated transcription. (A) Immunoblot showing knockdow
SMAR1, Flag-SMAR1 or scrambled SiRNA within a span of 42 h and p24 levels analyzed 24 h
other samples. (B) Basal virion production upon SMAR1 overexpression/ silencing by SiRNA.
virion production by SMAR1. HIV-1Molecular clones pNL4-3 or pYU-2were cotransfected wi
(FV) or pcTat and p24 counts were analyzed 48 h post infection. Transfection of SMAR1 siR
production.that may be adopted by viruses for conferring selective transcrip-
tional activation.
We further hypothesize that the afﬁnity of LTR-MAR to the nuclear
matrix might determine the transcriptional activity of the LTRs of
different strains of HIV. We show that SMAR1, a MARBP is responsible
for tethering of LTR to nuclear matrix causing repression of LTR-n of SMAR1 in ACH-2 cells. ACH-2 cells were transfected twice with SiRNA speciﬁc for
second Transfection. Control cells were treated with equal amounts of lipofectamine as
(C, D) Single-round virion production assays showing a dose dependent suppression of
th increasing concentrations of Flag-SMAR1 (FS), SiRNA speciﬁc for SMAR1, vector alone
NA or Tat enhances virus production whereas overexpression of SMAR1 reduced virus
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speciﬁcally to a hexanucleotide sequence present in the MAR
consensus element. Our database of MARs present in LTRs of all the
HIV isolates consisted of 24,512 bases. Of the 4096 all arithmetically
possible hexanucleotides, any one hexanucleotide can occur only six
times randomly in a given database of 24,512 bases. The hexanucleo-
tide sequence to which SMAR1 binds CAAAGA occurs 74 times in the
compiled database containing 219 sequences which is more than 12-
fold higher than that of expected random frequency which shows that
occurrence of these sequences in not random but highly speciﬁc and
conserved. There is a large amount of degeneracy within this
consensus which is expected in all the MAR sequences. This is
because, degeneracy allows two similar sequences to be regulated
differentially based on the factor recruitment or afﬁnity to bind to
nuclear matrix. Hence, degeneracy in MAR sequences is biologically
very relevant and important. Additionally, SMAR1 mediated recruit-
ment of HDAC1 to the LTR, leading to deacetylation of local histones.
The resultant change in chromatin environment decreases the
association of RNA Pol II with LTR thereby enforcing transcriptional
repression of the HIV provirus. We also found that PMA stimulation
abrogated the SMAR1 mediated repression of HIV promoter. It is
conceivable that the nuclear translocation of NF-κB and its binding to
the HIV promoter might alter local chromatin remodeling, thus
eliminating SMAR1 and its repressor complex from LTR. SMAR1
appears to exert transcriptional repression of HIV-1 promoter through
bimodal mechanisms: (1) directly by recruiting HDAC1/Sin3 repres-
sor complex and (2) by promoting the binding of nuclear matrix to
LTR. These bimodal actions of SMAR1 make it a strong negative
regulator of HIV transcription. However, further studies are needed to
determine the factors in nuclear matrix that bind to SMAR1 and how
they coordinate in causing transcriptional repression. Our studies
presented here strongly suggest SMAR1 as the likely candidate that
regulates the viral transcription dependent on the cue provided by the
cellular microenvironment. A follow up ofmolecular events that occur
at LTR upon activation with PMA or TNF-α show that SMAR1 binds to
LTR which is transcriptionally silent and upon its activation, SMAR1
rapidly falls off LTR. This gives rise to a cascade of events like
dissociation of HDAC1/Sin3A from LTR ultimately leading to transac-
tivation of LTR promoter. The dissociation of HDAC1 coincides with
the time of acetylation of histones and recruitment of p300 which
suggests that dissociation of SMAR1 from LTR is necessary for histone
acetylation to take place. There was also a decrease in trimethylation
at histone H4K20 upon activation which follows the same pattern as
association of SMAR1 with LTR. Thus it will be interesting to study if
SMAR1 can recruit any histone methyl transferases to LTR and causes
tri-methylation of histones. Our ﬁndings support an earlier model in
which the association of RNA Pol II can initiate transcription, but
cannot efﬁciently support elongation in the absence of Tat or NF-κB
(Bisgrove et al., 2005; Copeland, 2005). Thus, HIV transcription isFig. 7. SMAR1 tethers LTR to nuclear matrix. Schematic representation of molecular events be
Sin3A complex to HIV LTR and condenses chromatin at the LTR thereby downregulating LTessentially multifactorial and blocks occur at different levels in
different cells.
The results presented here suggest that recruitment of SMAR1/
HDAC1 complex anchors LTR to nuclear matrix maintaining a
repressive state. The ablation of this binding upon activation by
PMA leads to binding of NF-κB, p300 and other transcriptional
activators that resulting in activation of proviral transcription (Fig. 7).
This is strengthened by the observation that knockdown of SMAR1 in
latent ACH-2 cells lead to signiﬁcant increase in LTR transcription.
However, we believe that the observed residual HDAC1 bindingmight
be a result of LSF/YY-1, c-Myc, AP-4 or p50 mediated recruitment to
regions downstream of NRE. Thus, binding of SMAR1 and thus nuclear
matrix to LTR in line with the fact that recruitment of HDAC1 is a
general mode in which HIV transcription is regulated and the
repressor binding sites are spread all along the LTR to ensure proper
and coordinated regulation of gene expression. Nuclear matrix thus
forms a microenvironment to recruit co-regulatory factors for the
combinatorial regulation/modulation of gene expression in the three-
dimensional context of nuclear organization. Since HIV, HTLV and HPV
viral promoters contain MARs, it is tempting to speculate that viruses
have an inbuilt strategy of using host transcriptional regulatory
machinery through association with nuclear matrix which confers
transcriptional latency or activation, depending on the context.
Therefore, a detailed study of cellular factors that regulate transcrip-
tion of HIV may further enhance our understanding of HIV replication
in T-cells. This may lead to speciﬁc targeted therapies against
quiescent reservoir of HIV provirus in combination with other anti-
retroviral drugs.
Conclusions
Cellular pathogens and their hosts have co-evolved with mechan-
isms to counter and survive with each other. HIV-1 has cunningly
acquired tools to regulate and utilize many host factors for its own
propagation. So far we know that HIV integrates into the human
genome and uses cellular machinery to either be active in transcrip-
tion or be latent. However, the choice to be active or latent is made by
the virus or host is not known. We have identiﬁed for the ﬁrst time
that HIV itself harbors DNA sequences mimicking human genome.
This leads to binding of various critical host transcription factors like
SMAR1 to viral DNA and recruit other factors which decide the
transcriptionally active or latent conﬁguration of HIV genome. Such
mimicking also aids HIV in differentially partitioning itself between
active chromatin territories (ACTs) or associate with nuclear matrix
fraction to be transcriptionally latent. The present study also expands
our understanding of how SMAR1 represses HIV transcription.
Further, the anti-HIV activity of prostaglandins is shown to be
mediated by SMAR1. The binding site for SMAR1 is the same in all
subtypes of HIV-1, HIV-2 and even HTLV. Thus enhancing SMAR1fore and after activation. SMAR1 tethers LTR to nuclear matrix. SMAR1 recruits HDAC1/
R-mediated transcription upon activation.
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tion of many types of HIV.
Materials and methods
Plasmids and constructs
Cloning and expression of LTR-Luciferase construct, pcDNA-Tat
and plasmids expressing full length SMAR1 and various truncations
have been previously described (Pavithra et al., 2007). L1 (5′
CAAGATATCCTTGATCTGTGG) and L2 (5′ AAGGGGAACCAAGAGA)
primers were used for ampliﬁcation of the 1.5 kb region comprising
the 5′ LTR and its downstream sequence (1.5 kb LTR) from the HXB3
genomic clone of HIV-1 (NIH AIDS reagent program). The ampliﬁed
product was puriﬁed and cloned into pGEM-T easy which was then
cut out using EcoRI, Klenowed and further subcloned into the SmaI
site of SK+ (Stratagene), producing NC-1. NC-1 was digested with
XhoI and BamHI, and the resultant LTR fragment was cloned into
pGL3-Basic vector pre-digested with XhoI and BamHI (Promega), and
named LTR-Luc. pcDNA-Tat, the expression vector for Tat, was
constructed by cloning HXB3 Tat in pcDNA 3.1 using EcoRI and NotI
sites. pNL4-3 and pYU2 molecular clones were obtained from NIH
reagent and reference program.
Cell culture and transfections
293T, HeLa and TZM-bl cell lines were grown in Dulbecco's
Modiﬁed Eagles Medium (DMEM) supplemented with 10% FCS
(Invitrogen), 100 U/ml penicillin (Invitrogen), 100 μg/ml Strepto-
mycin (Invitrogen) and 2 mM L-glutamine in 5% CO2 humidiﬁed
atmosphere at 37°C and manipulated following treatment with 0.1%
Trypsin-EDTA (Invitrogen). CEM-GFP, Jurkat and ACH-2 cells were
grown in RPMI 1640 (Invitrogen) under similar conditions. Cells were
seeded at a density of 1–3 ×106 cells per 35 mm dish. Transfections
were done with indicated plasmids using Lipofectamine 2000 as per
manufacturer's instructions (Invitrogen). SiRNA speciﬁc for SMAR1
and control scrambled siRNA were synthesized from Ambion (SMAR1
siRNA [RS] sense, 5 GCAGAGCAUUGACUCCAAGTT; antisense, 5
CUUGGAGUCAAUGCUCUGCTT; scrambled siRNA sense, 5′ UACC-
GUAGGCAUGCAAAGCTT; antisense, 5′ AUGGCAUCCGUACGUUUCGTT ;
SMAR1 siRNA [NS] sense, 5′ GAGAAGCUAGACCUGGUCATT; antisense,
5 UGACCAGGUCUAGCUUCUCTT. For transfections in ACH-2 cells, cells
were grown overnight in serum-free media and transfections were
done twice with 24 h time between transfections to ensure better
efﬁciency using Lipofectamine 2000. Ten percent FCS was added 5 h
post transfection. Cells were activated with either 20 ng/ml of TNF-α
or 50 ng/ml PMA (Sigma) for 2 h unless otherwise indicated.
p24 ELISA
ELISA for p24 antigen was performed using standard ELISA kits
from Perkin Elmer according to the manufacturer's protocol. Brieﬂy,
all the samples were diluted in and 200 μl of each diluted sample was
used for the assay. Culture medium from uninfected cells was taken as
negative control. Quantitation was done by plotting absorbance
values against standard graph. All the assays were done in triplicate.
Viral production and cell Infection
For virus production, 5×106 HEK293T cells were transfected with
pNL4-3 molecular clone using Lipofectamine 2000 in 90-mm culture
dishes. After 16 h, themediumwas replacedwith completemedia and
supernatants containing viral particles were harvested 24 h later. The
number of infective viral particles per ml was established by infecting
1×104 HeLa based MAGI CD4+/CXCR4+/CCR5+ cells with different
amounts of viral suspension. The titer of the virus stock wasmeasuredas TCID50/ml by β-galactoside assay 72 h after infection and
subjecting the values to Spearmann–Karber formula.
Human PBMCs were isolated from fresh human blood using Ficoll
(Sigma) gradient. For infection in Jurkat cells and human PBMCs, the
indicated amounts of viral supernatant was incubated with 5×106
cells/ml in serum-free RPMI containing 0.4 μg/ml polybrene
(Sequabrene, Sigma) with intermittent tapping at 30 min intervals
for 6 h. The cells were then washed three times with RPMI and grown
in RPMI containing 10% FCS.
Immunoblotting and antibodies
Cells were scraped in 1× PBS and collected at indicated time points
and lysed using TNN buffer Equal amounts of proteins were taken for
immunoblotting following estimation by Bradford's reagent (BioRad).
Proteins resolved by SDS-PAGE, were electroblotted onto PVDF
membrane (Amersham). The membrane was blocked overnight in
Tris-buffered saline containing 0.1% Tween-20 (TBST) and 10% bovine
serum albumin (BSA). The membrane was then probed with primary
antibody in TBST for 2 h, followed by three 10-min TBST washes at
room temperature. Incubation with the secondary antibody was done
for 1 h, and three 10-min TBST washes were given prior to detection.
Proteins were detected using enhanced chemiluminescence substrate
(Amersham).
Electrophoretic mobility shift assay (EMSA)
For EMSA, oligonucleotide labeling was done by a Klenow reaction
using [α-32P] dCTP in a 20 μl reaction containing 1 mM dATG mix,
Klenow buffer, and 0.5 U of KlenowDNA polymerase (Invitrogen). The
sequences of all the oligos used are given in Table 1. Probe puriﬁcation
was done using Probequant G-50 column (Amersham Biosciences).
Binding reactions were performed in a 10 μl total volume containing
10 mM HEPES (pH 7.9), 1 mM dithiothreitol, 50 mM KCl, 2.5 mM
MgCl2, 10% glycerol, 0.5 to 1 μg double-stranded poly (dI-dC), 10 μg
BSA, and 1 μg of recombinant protein. GST-SMAR1 as well as GST
(160–350) and GST (350–548) truncation clones were puriﬁed as
described in Pavithra et al. (2007). Samples were incubated for 5 min
at room temperature prior to addition of radiolabeled probe. The
sampleswere then incubated for 15min at room temperature, and the
products of binding reactions were resolved by 8% native polyacryl-
amide gel electrophoresis. The gels were dried under vacuum and
processed for autoradiography.
Luciferase reporter assays
Forty hours after transfection, the culture medium was removed,
cells were washedwith phosphate buffered saline (PBS), resuspended
in 100 μl of cell lysis buffer. After two freeze–thaw cycles, cells were
centrifuged at 9500 rpm for 15 min and, protein concentration
estimated. Equal amounts of protein were used for the assays.
Luciferase activity assays were performed using Luclite substrate
(Perkin Elmer, USA) in Top-Count luminometer (Packard Life
sciences, USA). Graphs were plotted from data obtained as a mean
of three independent experiments along with computed standard
deviations as error bars.
ChIP analysis
Assays were performed using Chromatin Immunoprecipitation
(ChIP) assay kit (Upstate Biotechnology) following manufacturer's
instructions. 1×106 cells were plated per 30 mm dish and treated
with TNF-α or PMA or left untreated. After treatment, DNA–protein
interactions were ﬁxed by adding formaldehyde directly to the media
to a ﬁnal concentration of 1%, incubated at 37 °C for 10 min. Cell were
washed with PBS , pelletted and cells were lysed in SDS-lysis buffer by
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to clear the debris and chromatin extracts were incubated with 2 μg of
the indicated antibody or the isotype control at 4 °C overnight. The
antibody-chromatin complex was precipitated by adding protein A-
Sepharose bead, incubated for 4 h by rotating at 4 °C and centrifuged
at 3000 rpm for 5min. ChIP assays were carried out using anti-SMAR1,
anti-HDAC1, anti- acetyl Histone 3 Lysine-9 (H3K9), anti-Histone 4
Lysine 16 (H4K16), anti-RNA polymerase II, anti-phospho Serine 2
RNA Polymerase II, anti-phospho Serine 5 RNA Polymerase II, anti-
phospho Histone 3 Serine 10, anti-Histone 4 Lysine 20 tri-methyl
antibodies (Cell Signaling). Input DNA, Rabbit IgG (r-IgG), and Mouse
IgG (m-IgG) pulled DNA served as controls for all the experiments.
Immunoprecipitated DNA was then subjected to 30 cycles of semi
quantitative PCR using the primers mentioned below. The forward
and reverse primers used to amplify MAR respectively are 5′
GAAGTTTGACAGCCTCCTA and 5′ CTCCCCAGTCCCGCCCAGG. To am-
plify region downstream of LTR, primers used are 5 TGACTCA-
GATTGGCTGCAC and 5′ AATTTCTACTAATGCTTTA. The primers used to
amplify β-actin promoter were 5 GCCAGCAGCAAGCCTTGG and 5′
GCCACTGGGCCTCCATTC.
Preparation of nuclear matrix
Nuclear matrices from uninfected and HIV-1 infected cells lines
were prepared according to a well established protocol Cockerill and
Garrard, 1986a, 1986b). Cultured cells were washed once in PBS,
resuspended in RSB (10 mM NaCl; 3 mM MgCl2; 10 mM Tris–HCl;
0.5 mM PMSF, pH 7.4), incubated on ice for 10 min and then
homogenized with a Dounce homogenizer. Nuclei were pelletted by
centrifuging the samples at 6000 rpm for 10min. Nuclei in RSB, 0.25M
sucrose, and 1 mM CaCl2 were digested with 100 mg/ml DNAse I
(Sigma) for 2 h at 23 °C. After centrifugation for 10 min at 750 rpm at
4 °C, pellets were suspended in RSB-0.25 M sucrose, and an equal
volume of cold solution containing 4 M NaCl, 20 mM EDTA, and
20 mM Tris–HCl, (pH 7.4) was added. After centrifugation at
10,000 rpm for 10 min, pellets were extracted twice by suspension
in cold solution of 2 M NaCl, 10 mM EDTA, 10 mM Tris–HCl, 0.5 mM
PMSF, and 0.25 mg/ml BSA and centrifuged at 4 °C at 4500 rpm for
15 min. The resulting Nuclear Matrices were washed with RSB at 4 °C,
suspended in the same solution and stored at -80 °C.
Matrix binding assay
The assay was performed as previously described [28]. Nuclear
matrix isolated from 1×107 cells was suspended in 90 μl MAR-
binding buffer (20 mM Tris–HCl pH 7.4, 50 mM NaCl, 2 mM EDTA,
0.25 M Sucrose, and 0.25 mg/ml BSA). Sheared salmon sperm DNA
(100 μg/ml) and 5 ng/ml (50,000 cpm) 32p-labeled DNA fragments
fromMAR region of HIV-1 LTRweremixed and incubatedwith nuclear
matrix fraction at 25 °C for 4 h with constant gentle shaking. Reaction
mixture was diluted with 1 ml binding buffer, centrifuged and the
matrix-bound fragments were solubilized in 0.5% SDS. The soluble
mixture was treated with 0.5 mg/ml Proteinase K for 5 h, phenol–
chloroform extracted, ethanol precipitated and ﬁnally resolved on an
8% polyacrylamide–0.1% SDS gel. For in vivo matrix binding assays,
nuclear matrix and chromatin fractions were isolated from activated
or unactivated 5×107 exponentially growing TZM-bl or CEM-GFP
cells and bound DNA fragments isolated by phenol-chloroform-
isoamylalcohol method. DNA isolated from these fractions were
subjected to PCR for quantifying the amount of LTR present in matrix
or chromatin fractions.
South-Western blotting
South-Western blotting as per protocols established by Raziuddin
et al. with minor modiﬁcations. Protein from nuclear matrix (10 and20 μg) was resolved by 10% SDS PAGE, electrotransferred onto PVDF
membrane. The membrane was prehybridized for 2 h at room
temperature with buffer containing 10 mM HEPES and 5% BSA
(Amersham) and then hybridized with buffer containing 10 mM
HEPES (pH7.9), 50mMNaCl, 1mMEDTA, 1mMDTT, 0.5%BSA, 5 μg/ml
heat denatured sheared salmon sperm DNA (Sigma) and 1×105 cpm
of 32p-labeled LTR probes for 1 h at room temperature with constant
agitation. The blot was then washed three times for 20 min each at
room temperature with the same buffer with 300 mM NaCl, air-dried
and exposed for autoradiography.
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